| 000 | 01696 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516212059.0 | ||
| 264 | 0 | _c20150417 | |
| 008 | 201504s 0 0 eng d | ||
| 022 | _a1534-4681 | ||
| 024 | 7 |
_a10.1245/s10434-014-3679-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan der Ploeg, Augustinus P T | |
| 245 | 0 | 0 |
_aMelanoma patients with an unknown primary tumor site have a better outcome than those with a known primary following therapeutic lymph node dissection for macroscopic (clinically palpable) nodal disease. _h[electronic resource] |
| 260 |
_bAnnals of surgical oncology _cSep 2014 |
||
| 300 |
_a3108-16 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymph Node Excision _xmortality |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _xmortality |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aNeoplasms, Unknown Primary _xmortality |
| 650 | 0 | 4 |
_aPostoperative Complications _xmortality |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSkin Neoplasms _xmortality |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aHaydu, Lauren E | |
| 700 | 1 | _aSpillane, Andrew J | |
| 700 | 1 | _aScolyer, Richard A | |
| 700 | 1 | _aQuinn, Michael J | |
| 700 | 1 | _aSaw, Robyn P M | |
| 700 | 1 | _aShannon, Kerwin F | |
| 700 | 1 | _aStretch, Jonathan R | |
| 700 | 1 | _aThompson, John F | |
| 773 | 0 |
_tAnnals of surgical oncology _gvol. 21 _gno. 9 _gp. 3108-16 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1245/s10434-014-3679-5 _zAvailable from publisher's website |
| 999 |
_c23802061 _d23802061 |
||